This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Data Disclosure Europe
21-22 October, 2025
Hotel Palace BerlinBerlin, Germany

Gosia Sztolsztener
Director, Clinical Trial Transparency Patient Engagement at AstraZeneca
Speaker

Profile

Malgorzata Sztolsztener is the Director of Clinical Trial Transparency Patient Engagement for AstraZeneca. Before joining AstraZeneca, Malgorzata worked in a postdoctoral position at one of the top research centers in Poland. Malgorzata has been with AstraZeneca for 10 years now, initially she specialized in Clinical Trial Disclosure of technical results. Since 2018 she has led the delivery of Trial Results Summaries and other patient communications written in an easy-to-understand language to participants of AstraZeneca clinical trials globally. As part of her role, Malgorzata is also involved in several industry workstreams focused on establishing and implementing best practices in Clinical Trial Transparency and Health Literacy.

Agenda Sessions

  • What’s stopping AI? Considerations for Use in PLS and Implementation Roadblocks

    09:00